ArticleAlzheimer's & dementia (Amsterdam, Netherlands)
Lecanemab in symptomatic PSEN1 p.Met233Val early-onset Alzheimer's disease: Neuroimaging safety, regional amyloid-PET dynamics, and longitudinal plasma biomarkers.
Min-Young Noh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.